Cardiol Therapeutics Inc (CRDL)

04:35 AM

Atria Investments Inc Takes Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

04:35 AM

Mar 14, 2025

Cardiol Therapeutics Schedules Annual General Meeting for May 2025 - TipRanks

Mar 14, 2025

Mar 06, 2025

Financial Comparison: Cardiol Therapeutics (NASDAQ:CRDL) versus Cortexyme (NASDAQ:CRTX) - Defense World

Mar 06, 2025

Mar 03, 2025

Cardiol Therapeutics to Present at TD Cowen Health Care Conference - TipRanks

Mar 03, 2025

Mar 03, 2025

Cardiol Therapeutics to present at health care conference - Proactive Investors USA

Mar 03, 2025

Mar 03, 2025

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference - Newsfile

Mar 03, 2025

Feb 27, 2025

Cardiol Therapeutics (TSE:CRDL) Hits New 12-Month LowWhat's Next? - MarketBeat

Feb 27, 2025

Feb 26, 2025

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302 - Investing News Network

Feb 26, 2025

Feb 26, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Receives Buy Rating from HC Wainwright - MarketBeat

Feb 26, 2025

Feb 25, 2025

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.40 Average PT from Analysts - Defense World

Feb 25, 2025

Feb 24, 2025

Promising Potential of Cardiol Therapeutics’ CRD-38 Justifies Buy Rating Amidst Market Need for HFpEF Treatment - TipRanks

Feb 24, 2025

Feb 22, 2025

Cardiol Therapeutics Inc. - MENAFN.COM

Feb 22, 2025

Feb 21, 2025

JACC data highlights Cardiol’s potential to differentiate in HF space - Yahoo Finance

Feb 21, 2025

Feb 20, 2025

Cardiol Therapeutics reports heart failure treatment progress By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

Cardiol Therapeutics says study shows benefit of cannabidiol drug in treating heart failure - Proactive financial news

Feb 20, 2025

Feb 20, 2025

Cardiol Therapeutics reports heart failure treatment progress - Investing.com India

Feb 20, 2025

Feb 20, 2025

Cardiol Therapeutics Advances Heart Failure Treatment with New Research Publication - TipRanks

Feb 20, 2025

Feb 20, 2025

Revolutionary Heart Failure Treatment Shows Promise: Top Medical Journal Validates Multiple Therapeutic Benefits - StockTitan

Feb 20, 2025

Feb 19, 2025

Cardiol Therapeutics: Bargain Stock Price With Share Price Appreciation Catalysts (NASDAQ:CRDL) - Seeking Alpha

Feb 19, 2025

Feb 13, 2025

Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx(TM) for Treatment of Acute Myocarditis - Newsfile

Feb 13, 2025

Feb 13, 2025

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot - Newsfile

Feb 13, 2025

Feb 13, 2025

Biogen (NASDAQ:BIIB) vs. Cardiol Therapeutics (NASDAQ:CRDL) Head to Head Contrast - Defense World

Feb 13, 2025

Feb 11, 2025

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.7%What's Next? - MarketBeat

Feb 11, 2025

Feb 08, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Down 7.7% – Time to Sell? - Defense World

Feb 08, 2025

Feb 07, 2025

Cardiol Therapeutics (OTCMKTS:CRTPF) Trading 5.3% Higher – Here’s Why - Armenian Reporter

Feb 07, 2025

Feb 06, 2025

Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Up 5.3% – Time to Buy? - Defense World

Feb 06, 2025

Feb 04, 2025

Cardiol Therapeutics to present at Oppenheimer Healthcare Conference - Proactive Investors UK

Feb 04, 2025

Feb 04, 2025

Cardiol Therapeutics to Present at Healthcare Conference, Highlighting Advances in Heart Disease Therapies - TipRanks

Feb 04, 2025

Feb 04, 2025

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Newsfile

Feb 04, 2025

Feb 04, 2025

Heart Disease Breakthrough: Cardiol Therapeutics Unveils Latest Research at Major Healthcare Summit - StockTitan

Feb 04, 2025

Feb 03, 2025

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol - Yahoo Finance

Feb 03, 2025

Feb 02, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Rating Increased to Strong-Buy at RODMAN&RENSHAW - MarketBeat

Feb 02, 2025

Feb 01, 2025

Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) PT at $8.40 - MarketBeat

Feb 01, 2025

Feb 01, 2025

Reviewing Cardiol Therapeutics (NASDAQ:CRDL) and CG Oncology (NASDAQ:CGON) - Defense World

Feb 01, 2025

Jan 31, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated by Analysts at Rodman & Renshaw - MarketBeat

Jan 31, 2025

Jan 31, 2025

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era - Yahoo Finance

Jan 31, 2025

Jan 31, 2025

Brokerages Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Price Target at $8.40 - Defense World

Jan 31, 2025

Jan 30, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at RODMAN&RENSHAW - Defense World

Jan 30, 2025

Jan 30, 2025

Rodman & Renshaw Begins Coverage on Cardiol Therapeutics (NASDAQ:CRDL) - Defense World

Jan 30, 2025

Jan 28, 2025

Rodman & Renshaw sets $7 target on Cardiol Therapeutics stock - MSN

Jan 28, 2025

Jan 28, 2025

Rodman & Renshaw sets $7 target on Cardiol Therapeutics stock By Investing.com - Investing.com Canada

Jan 28, 2025

Jan 17, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Down 3.4%What's Next? - MarketBeat

Jan 17, 2025

Jan 17, 2025

Jane Street Group LLC Takes $29,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

Jan 17, 2025

Jan 17, 2025

Cardiol Therapeutics (TSE:CRDL) Shares Down 3.4% – Here’s What Happened - Defense World

Jan 17, 2025

Jan 15, 2025

Critical Comparison: Black Diamond Therapeutics (NASDAQ:BDTX) & Cardiol Therapeutics (NASDAQ:CRDL) - Defense World

Jan 15, 2025